47 related articles for article (PubMed ID: 18779714)
1. The safety of intraocular methotrexate in silicone-filled eyes.
Hardwig PW; Pulido JS; Bakri SJ
Retina; 2008 Oct; 28(8):1082-6. PubMed ID: 18779714
[TBL] [Abstract][Full Text] [Related]
2. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
[TBL] [Abstract][Full Text] [Related]
3. Unusual presentation of cornea verticillata with intravitreal methotrexate in a case of primary intraocular lymphoma.
Hasan N; Narde HK; Das AK; Chawla R
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35027386
[TBL] [Abstract][Full Text] [Related]
4. Intraocular methotrexate for epithelial downgrowth: long-term outcomes in a multicentre case series.
Hébert M; Kyrillos R; Snyder ME; Mackool RJ; Francis JH; Wu HK; Riemann CD; Légaré ME
Br J Ophthalmol; 2023 Sep; 107(9):1383-1389. PubMed ID: 35649694
[TBL] [Abstract][Full Text] [Related]
5. The Preservation of the Eyes.
West J Med Surg; 1853 Mar; 11(3):267-270. PubMed ID: 38210525
[No Abstract] [Full Text] [Related]
6. Repeated Injection of Methotrexate into Silicone Oil-Filled Eyes for Grade C Proliferative Vitreoretinopathy: A Pilot Study.
Nourinia R; Borna F; Rahimi A; Jabbarpoor Bonyadi MH; Amizadeh Y; Daneshtalab A; Kheiri B; Ahmadieh H
Ophthalmologica; 2019; 242(2):113-117. PubMed ID: 31163427
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal methotrexate infusion for proliferative vitreoretinopathy.
Sadaka A; Sisk RA; Osher JM; Toygar O; Duncan MK; Riemann CD
Clin Ophthalmol; 2016; 10():1811-1817. PubMed ID: 27698550
[TBL] [Abstract][Full Text] [Related]
8. Proliferative Vitreoretinopathy: A Reappraisal.
Carpineto P; Licata AM; Ciancaglini M
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629329
[TBL] [Abstract][Full Text] [Related]
9. Using Advanced Bioinformatics Tools to Identify Novel Therapeutic Candidates for Proliferative Vitreoretinopathy.
Xie EF; Xie B; Nadeem U; D'Souza M; Reem G; Sulakhe D; Skondra D
Transl Vis Sci Technol; 2023 May; 12(5):19. PubMed ID: 37191619
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized, Gas-Phase, Intravitreal Methotrexate Reduces Proliferative Vitreoretinopathy in a Randomized Trial in a Porcine Model.
Olsen TW; Asheim CG; Salomao DR; Hann CR; Wabner K; Schmit J; Naqwi A
Ophthalmol Sci; 2023 Sep; 3(3):100296. PubMed ID: 37113472
[TBL] [Abstract][Full Text] [Related]
11. Intraocular Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy: A Review.
McAllister MA; Moore SM; Bullock B; Christoforidis JB
J Vitreoretin Dis; 2023; 7(2):144-153. PubMed ID: 37006665
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review of intravitreal immunosuppressants and biologicals used in ophthalmology.
Hasan N; Chawla R; Shaikh N; Kandasamy S; Azad SV; Sundar MD
Ther Adv Ophthalmol; 2022; 14():25158414221097418. PubMed ID: 35602659
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Methotrexate.
Abdi F; Mohammadi SS; Falavarjani KG
J Ophthalmic Vis Res; 2021; 16(4):657-669. PubMed ID: 34840688
[TBL] [Abstract][Full Text] [Related]
14. Anatomical and Functional Outcomes of Vitrectomy with/without Intravitreal Methotrexate Infusion for Management of Proliferative Vitreoretinopathy Secondary to Rhegmatogenous Retinal Detachment.
El Baha S; Leila M; Amr A; Lolah MMA
J Ophthalmol; 2021; 2021():3648134. PubMed ID: 34336257
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy as an adjunct to vitrectomy.
Villegas VM; González MP; Berrocal AM; Murray TG
Ther Adv Ophthalmol; 2021; 13():25158414211016105. PubMed ID: 34104868
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive serial post-operative intravitreal methotrexate injections in the management of advanced proliferative vitreoretinopathy.
Roca JA; Yon-Mendoza A; Huamán N; Wu L
Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):2913-2917. PubMed ID: 33900444
[TBL] [Abstract][Full Text] [Related]
17. Acupuncture resulting in eye penetration and proliferative vitreoretinopathy - Surgical and medical management with intraocular methotrexate.
Denstedt J; Schulz DC; Diaconita V; Sheidow TG
Am J Ophthalmol Case Rep; 2020 Jun; 18():100605. PubMed ID: 32181412
[TBL] [Abstract][Full Text] [Related]
18. Proliferative Vitreoretinopathy: A Review.
Idrees S; Sridhar J; Kuriyan AE
Int Ophthalmol Clin; 2019; 59(1):221-240. PubMed ID: 30585928
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month follow-up study.
Falavarjani KG; Golabi S; Modarres M
Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2159-2164. PubMed ID: 27145784
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
